Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Kidney Int ; 99(6): 1275-1279, 2021 06.
Article in English | MEDLINE | ID: covidwho-1272596

ABSTRACT

In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-naïve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response.


Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/immunology , COVID-19/prevention & control , Kidney Transplantation , Renal Dialysis , Aged , COVID-19/complications , COVID-19 Vaccines/adverse effects , Female , Humans , Immunity , Male , Middle Aged , Outcome and Process Assessment, Health Care , Pandemics/prevention & control , Renal Replacement Therapy , SARS-CoV-2 , Vaccination
8.
Non-conventional | WHO COVID | ID: covidwho-354068

ABSTRACT

The clinical presentation and mortality rate in maintenance hemodialysis (MHD) patients with COVID-19 are not well established. Recent data from Italy and Spain suggest that these patients present with wide range of symptoms, with a significant portion being asymptomatic. There is prolonged positivity of pharyngeal swabs in MHD patients. The mortality rates are very high, reaching almost 30%. These data highlight the importance of diligent oversight and care of MHD patients during COVID-19 pandemic.

SELECTION OF CITATIONS
SEARCH DETAIL